Background: Recently, more clinicians have realized the importance of quality of life in the treatment decision-making
I
n the 1930s, the concept of quality of life, which focused on the patient's feelings and experience after treatment, was raised in the Unites States. Since then, there has been growing consensus that traditional treatment goals, such as improvement in survival rates, are not appropriate in most palliative treatments whereas improving quality of life is crucial [1] [2] [3] . Lung cancer is the most common type of cancer in the world and is also the leading cause of cancer-related deaths 4 . Non-small-cell lung cancer (NSCLC) accounts for about 80% to 85% of lung cancer diagnoses, and 30% to 40% of patients with late NSCLC develop bone metastases, most of which involve the spine 5, 6 . Spinal metastases can cause intractable pain, pathological fracture, spinal instability, hypercalcemia, or even paralysis due to spinal cord compression, which can lower the quality of life of these patients 7 . Spinal metastases of NSCLC are incurable, so the decision-making process should focus on improving quality of life and extending life as much as possible.
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Surgery had gradually become the chief method to treat spinal metastases of cancer [8] [9] [10] . Surgical intervention is helpful in improving the neurological function of patients with spinal metastases, but further investigation is needed to determine whether it can improve their quality of life or prolong their survival. The literature dealing with the quality of life of patients with spinal metastases of NSCLC is limited. Thus, we conducted a prospective, longitudinal, observational study to evaluate the quality of life and the life spans of patients with spinal metastases of NSCLC in order to provide useful insight into the clinical decision-making process for these patients.
Materials and Methods

Patients and Procedures
O ne hundred and thirty-three patients who were admitted to our hospital with spinal metastases of NSCLC between January 2010 and June 2014 were eligible for this study. The inclusion criteria were (1) an age of more than eighteen years, (2) pathologically confirmed spinal metastases of NSCLC, (3) a neurological deficit or spinal symptoms, (4) indications for surgery, (5) an estimated survival time of more than three months, and (6) a prognostic score of <8 according to the system described by Tomita et al.
11
. The exclusion criteria were (1) a pathologically confirmed primary spinal tumor or metastasis of another type of cancer, (2) previous surgery for spinal tumor, (3) complete paraplegia for more than seventy-two hours, and (4) a health condition that made the patient too weak to have surgery.
Surgery was recommended to all eligible patients. After a comprehensive and detailed explanation to the patient and family about the risks and benefits of the surgery, the cost of the surgery, and other adjuvant therapies, the patient and family decided to either follow or not follow the recommendation for surgery. Sixty-eight patients opted for surgery and thus were included in the surgery group for this study, and sixty-five declined surgery and were included in the nonsurgery group. The surgical strategy was individualized for each patient in the surgery group mainly on the basis of the Tomita score 11 . Seven patients with involvement of a single thoracic or lumbar vertebra underwent total en bloc spondylectomy with reconstruction, through a posterior approach (average blood loss, 1986 mL). The remaining sixty-one patients underwent subtotal resection or total piecemeal spondylectomy and/or laminectomy with reconstruction, through a posterior approach for thoracic and lumbar vertebrae and through an anterior or anterior-posterior approach for cervical vertebrae (average blood loss, 1632 mL). Written informed consent for inclusion in the study was obtained from all patients, and written informed consent for operative treatment was obtained from all patients in the surgery group. Subsequent postoperative multimodal treatment, including chemotherapy, radiation therapy, and bisphosphonate therapy, was given to patients in the surgery group. Patients in the non-surgery group received the same combination of therapies immediately after diagnosis.
Instrument for Assessment of Quality of Life
The Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire is one of the most widely used questionnaires for assessing the quality of life of patients with diverse tumor types 12 and has been validated as suitable for the Chinese population 13 . The FACT-G questionnaire (version 4.0) is a patient self-reporting instrument that assesses different aspects of quality of life. It contains four domains: physical well-being (seven items), social/family well-being (seven items), emotional well-being (six items), and functional well-being (seven items). Each item is measured on a scale ranging from 0 (not at all) to 4 (very much). The maximum total score of all items is 108. A higher total score indicates a better quality of life.
Follow-up Strategy
The Chinese-language version of the FACT-G questionnaire was administered at baseline (before any treatment was given) and at one, three, six, and nine months after diagnosis. The patients received and returned the questionnaires by mail or e-mail and were contacted by telephone if any items were missing. For patients who survived for less than nine months after the initial diagnosis, the quality-of-life assessments were performed up to the last follow-up interval at which they were alive.
Statistical Analysis
The baseline data were compared between the surgery and non-surgery groups by using a chi-square test for dichotomous variables and a t test for continuous variables. A nonparametric test was used for skewed variables. The changes in quality of life over time within the same group and between the two groups were identified by using repeated-measures analyses of variance. Then paired t tests were used to compare the scores at one, three, six, and nine months with the baseline score in each of the two groups. Kaplan-Meier curves were obtained, and overall survival was compared between the two groups by using the log-rank test. P < 0.05 was considered significant, and a power analysis was conducted. Statistical analyses were performed by using SPSS for Windows, version 16.0.0 (SPSS).
Results
Demographic Data
T he baseline characteristics of the 133 patients are shown in Table I . There was no statistically significant difference between the two groups with regard to any parameter. In the surgery group, sixty-eight patients (100%) received chemotherapy, forty-two (62%) received radiation therapy to treat the spinal Comparison of the mean FACT-G quality-of-life (QOL) scores of patients who completed the five time-point assessments (forty-five in the surgery group and forty-one in the non-surgery group) showed significant differences between the two groups over the nine-month follow-up period in the domains of physical well-being ( Fig. 1-A) , emotional well-being ( Fig. 1-C) , and functional well-being ( Fig. 1-D) (p < 0.001 for all) but not in the domain of social/family well-being ( Fig. 1-B) (p = 0.188). 398
metastasis, thirty-one (46%) received radiation therapy to treat the primary lesion of the lung, twenty-six (38%) received targeted therapy, and sixty (88%) received bisphosphonate therapy. The corresponding numbers of patients in the non-surgery group were sixty-three (97%), forty-nine (75%), twenty-nine (45%), twenty-eight (43%), and fifty-six (86%).
Quality of Life
FACT-G scores were obtained at all five time points for eighty-six patients, including forty-five in the surgery group and forty-one in the non-surgery group. The total scores and the subscores in the four specific life domains obtained at the five time points, as well as the results of the statistical analyses of these scores, are listed in Table  II . Repeated-measures analysis showed significant differences in all domains between the surgery and non-surgery groups (p < 0.001). An interaction analysis showed an effect between "time" and "group" in three of the domains and for the total score (p < 0.001). Figure 1 shows the changes in the quality-of-life scores in each domain over the follow-up period from baseline to nine months, and Figure 2 shows the changes in the mean total qualityof-life scores during that follow-up period. The mean total quality-of-life scores in the surgery group were higher than those in the non-surgery group (p < 0.001). A meaningful increase in the quality of life was noted immediately after the surgery in the surgery group. The scores in that group increased with time, peaking at three months after surgery, and were largely maintained throughout the postoperative follow-up period. However, the non-surgery group had a significant deterioration in quality-of-life scores in all domains from baseline to one, three, and six months, and the scores reached their lowest point at nine months. Figure 1 -A illustrates how the pattern of the physical wellbeing scores in the surgery group differed from that in the nonsurgery group (p < 0.001). A sharp increase was observed at three months after surgery in the surgery group, while there was a sharp decrease over time in the non-surgery group. Similar patterns were found for emotional ( Fig. 1-C) and functional ( Fig. 1-D) well-being (p < 0.001), but there was no statistically . 2 Comparison of the mean total FACT-G quality-of-life (QOL) scores of patients who completed the five time-point assessments (forty-five in the surgery group and forty-one in the non-surgery group) showed significant differences between the two groups over the nine-month follow-up period (p < 0.001). Fig. 3 Kaplan-Meier curves illustrating overall survival of the surgery and non-surgery groups (chi square = 5.424, p = 0.020, log-rank test). 
significant difference in the social/family well-being scores between the two groups over time ( Fig. 1-B ) (p = 0.188).
Survival Analysis
At the end of the study, seven patients had been lost to follow-up; the remaining 126 (sixty-five in the surgery group and sixty-one in the non-surgery group) were included in the survival analysis (Fig. 3) . Twenty-five patients (38%) in the surgery group and ten (16%) in the non-surgery group were still alive at the time of the final analysis for this study (April 2015). The median survival time was fourteen months in the surgery group and thirteen months in the non-surgery group. The one, two, and three-year survival rates were 66.0%, 39.0%, and 17.4% in the surgery group and 52.5%, 17.0%, and 6.8% in the non-surgery group. A logrank test indicated that surgery increased survival in patients with spinal metastasis of NSCLC (chi square = 5.424, p = 0.020).
Discussion
P atients with cancer care not only about whether the disease can be cured and how long they can survive, but also about side effects of treatment and how much the treatment can improve their quality of life. Therefore, surgeons have placed a strong emphasis on the quality of life of patients when considering treatment for them 12, 14, 15 . Quality-of-life assessments have been used in many randomized clinical trials, especially those involving incurable diseases 16, 17 . In the current study, 90% of patients presented with pain or neurological symptoms instead of lung-cancer-related symptoms such as a cough, hemoptysis, or dyspnea. Two (3%) of the sixty-eight patients in the surgery group had liver metastasis and three (5%) of the sixty-five in the non-surgery group had brain metastasis; however, none developed related symptoms. For this reason, we chose the FACT-G questionnaire instead of the FACT-L (Lung) questionnaire as the instrument for the quality-of-life assessment, even though all of the patients in the study had been diagnosed with spinal metastasis of lung cancer at presentation.
In this study, the surgery group had a better physical, emotional, functional, and overall status than the non-surgery group, indicating that surgery can improve the quality of life of patients with spinal metastases of NSCLC as assessed with the FACT-G instrument. In the non-surgery group, the FACT-G scores decreased with time and reached their lowest point at the nine-month follow-up, which suggested that non-surgical treatments such as radiation therapy, chemotherapy, and bisphosphonate treatment did not improve the quality of life in this specific group of patients for whom surgery had been recommended and should not be utilized as the first-line treatment, but only as an adjuvant to surgery.
The goals of the surgery were to remove the tumors, decompress the spinal cord, control pain, and maintain the stability of the spine. The significant improvements in physical and functional well-being in the surgery group are likely related to increases in scores for specific items in the two domains that are improved by surgery, such as "I have pain," "I am forced to spend time in bed," and "I feel ill" in the physical function domain and "I am able to work (include work at home)," "I am sleeping well," and "I am able to enjoy life" in the functional domain.
In the surgery group, the scores for items in the emotional well-being domain such as "I feel sad," "I am satisfied with how I am coping with my illness," and "I worry about dying" gradually increased after surgery at first and then decreased slightly, but were still above the baseline at nine months. We thought that was due to the evolutionary course of NSCLC. Therefore, effective control of the primary cancer is vital.
In the non-surgery group, the scores in the emotional wellbeing domain fluctuated without significant changes over time, which might have been due to the uncertain therapeutic effect of radiation therapy, chemotherapy, or bisphosphonate treatment. It is well known that radiation therapy can relieve the pain caused by spinal metastases, but it was not very effective in relieving the pain associated with NSCLC. Thus, when the NSCLC progressed, pain would appear and become more intense. Chemotherapy, when effective, controlled the NSCLC or even resulted in shrinkage of the tumor. Subsequently, at first the treatment effect enhanced the confidence of the patients regarding their fight against the disease, resulting in higher emotional well-being scores. However, when resistance to the chemotherapy developed or side effects occurred and the patients could not tolerate the treatment, their psychological status changed.
The scores in the social/family well-being domain did not change significantly over time in this study. The reason for this might be related to the traditional family values of Chinese people and the insufficient social medical insurance systems. In the People's Republic of China, patients with advanced cancer are usually cared for by their families and the cost of treatment is also borne mainly by the families. Thus, no matter what kind of treatments the patients received and how much their disease worsened, they mostly relied, both mentally and financially, on their families, relatives, and friends.
Another noteworthy observation in our study was that the survival time was longer in the surgery group than in the nonsurgery group (p = 0.020, log-rank test). This was in contrast with the finding in an earlier study that spinal surgery did not provide benefits in terms of quality of life or survival for patients with spinal metastases from hepatic cell cancer 18 . Another study showed that, regardless of the cancer type, surgery appeared to significantly improve the overall quality of life, with the exception of survival time, of patients with spinal metastases 19 . We hypothesized that whether or not surgery benefits patients with spinal metastases depends on the specific type of primary tumor with which the patient presents. In a randomized trial of 101 patients with spinal cord compression caused by metastatic cancer, Patchell et al. 8 found that patients who had undergone direct decompressive surgery and postoperative radiation therapy survived longer than those who had been treated with radiation therapy alone. However, that study had a short follow-up that was not long enough for the authors to draw a conclusion that surgery could prolong the survival of patients with spinal metastases. We chose patients with spinal metastases of NSCLC to minimize the selection bias caused by cancer types and because of the poor prognosis associated with NSCLC (a five-year survival rate of 10% to 20% 7, 10 ) as it enabled us to easily see the effect of surgery on patients' survival.
Recently, several studies have demonstrated the prognostic value, in terms of increasing survival, of quality of life measured after treatment [20] [21] [22] , which is in line with what we indicated in this paper. Pain, pathological vertebral fracture, and spinal cord compression caused by the NSCLC metastases often made a tremendous difference in the patients' quality of life and can reduce patients' tolerance of radiation therapy, chemotherapy, and other auxiliary treatments, shortening the time to death. Because surgery can relieve pain and stress and improve neurological function, it can increase patients' tolerance of other auxiliary treatments. It was reported that chronic stress was associated with suppression of immune function 23, 24 . By freeing patients from the stress caused by pain or paralysis, surgery might act as an emotional intervention, improving the patient's emotional state and therefore enhancing immunity, helping the patient to fight cancer 25 . Conservative treatments alone had no therapeutic effect on the neurological deficit. Consequently, as the disease progressed, many patients had to remain in bed, paralyzed and often depressed 26 , which might also explain the longer survival of patients who underwent surgery in our study.
Spinal tumor surgery is risky and difficult. In a study by Chen et al., five of thirty-one patients with NSCLC spinal metastases had surgery-related complications, including surgical site infection, respiratory failure, and leakage of cerebrospinal fluid, but no patients died in the perioperative period 9 . The thirty-day mortality rate after surgery for spinal metastases has been reported to be approximately 3% to 5% 27 . In our study, five patients developed a controllable surgical site infection and no patients died within thirty days after surgery, which showed that surgery was an effective treatment modality with benefits that outweighed the risks for patients who had a neurological deficit and spinal cord compression due to NSCLC metastases.
Several limitations of the study should be mentioned. First, it was a nonrandomized controlled study. All patients had indications for spine surgery, which inevitably created patient selection bias. However, the patient and his or her family decided whether he or she should undergo surgery. Also, we tried to balance the two groups at study entry, and the groups did not differ with regard to the baseline characteristics of age, sex, Frankel score, and overall quality of life. Second, most of the patients in our study did not present with symptoms of the primary NSCLC such as a cough, expectoration, or dyspnea. Thus, the conclusions of this article might not apply to patients with primary symptoms. Third, ten patients in the non-surgery group and twenty-five in the surgery group were still alive at the time of the final analysis for this study (April 2015); these "censored data" (ten and twentyfive) partly lowered the reliability of the survival analysis.
In conclusion, the results of this study of patients with NSCLC spinal metastases indicate that surgical treatment improved quality of life over the nine-month assessment period. Compared with the non-surgery group, patients in the surgery group had a higher quality of life and longer survival time. n
